Panther(R) System, Catalog Number 902615, For Use with Hologic Assays, For In Vitro Diagnostic Use
FDA Device Recall #Z-0027-2018 — Class II — September 15, 2017
Recall Summary
| Recall Number | Z-0027-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 15, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Hologic, Inc |
| Location | San Diego, CA |
| Product Type | Devices |
| Quantity | 1 unit |
Product Description
Panther(R) System, Catalog Number 902615, For Use with Hologic Assays, For In Vitro Diagnostic Use
Reason for Recall
An incorrect incubator was installed on one Panther System which potentially led to incorrect Aptima Combo 2(R) assay (AC2) results.
Distribution Pattern
Indiana
Lot / Code Information
Serial Number 20900001124
Other Recalls from Hologic, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1314-2026 | Class II | Brevera Breast Biopsy System Disposable 9 Gauge... | Dec 15, 2025 |
| Z-1093-2026 | Class II | ThinPrep¿ CytoLyt¿ Solution. Buffered Cell Wash... | Dec 12, 2025 |
| Z-1170-2025 | Class II | Brand Name: Sertera Biopsy Device Product Name... | Jan 15, 2025 |
| Z-0328-2025 | Class I | BioZorb Marker. Radiographic soft tissue marker. | Oct 10, 2024 |
| Z-1733-2024 | Class I | BioZorb Marker-BioZorb 3D Bioabsorbable Marker-... | Mar 13, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.